Back to Search
AARON RIVKIN, MD
MD
Addiction Medicine (Family Medicine) Physician
NPI: 1629561063IndividualAccepts Medicare
Specialties, Licenses & Credentials
Addiction Medicine (Family Medicine) PhysicianPrimary
Family Medicine — Addiction Medicine
Code: 207QA0401X
4301504376(MI)
Education
WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE
Class of 2018
Research & Publications (20)
3-Aryl-4-hydroxyquinolin-2(1H)-one derivatives as type I fatty acid synthase inhibitors.
PMID 16784844·Bioorg Med Chem Lett·2006
7-preclinical
On the remarkable antitumor properties of fludelone: how we got there.
PMID 15880547·Angew Chem Int Ed Engl·2005
6-review
Discovery of (E)-9,10-dehydroepothilones through chemical synthesis: on the emergence of 26-trifluoro-(E)-9,10-dehydro-12,13-desoxyepothilone B as a promising anticancer drug candidate.
PMID 15339176·J Am Chem Soc·2004
7-preclinical
Radical and palladium-catalyzed cyclizations to cyclobutenes: an entry to the BCD ring system of penitrem D.
PMID 15153001·J Org Chem·2004
8-other
Application of ring-closing metathesis reactions in the synthesis of epothilones.
PMID 14987048·J Nat Prod·2004
6-review
Complex target-oriented total synthesis in the drug discovery process: the discovery of a highly promising family of second generation epothilones.
PMID 12617656·J Am Chem Soc·2003
8-other
Samarium(II) iodide mediated radical/polar crossover reactions of cyclobutenes. An efficient approach to the BCD ring system of the penitrems.
PMID 12583733·Org Lett·2003
8-other
On the introduction of a trifluoromethyl substituent in the epothilone setting: chemical issues related to ring forming olefin metathesis and earliest biological findings.
PMID 12423091·Org Lett·2002
8-other
Total syntheses of [17]- and [18]dehydrodesoxyepothilones B via a concise ring-closing metathesis-based strategy: correlation of ring size with biological activity in the epothilone series.
PMID 12398497·J Org Chem·2002
8-other
New fillers under consideration: what is the future of injectable aesthetics?
PMID 19415580·Facial Plast Surg·2009
8-other
Compositional differences between meteorites and near-Earth asteroids.
PMID 18704080·Nature·2008
8-other
Panitumumab: human monoclonal antibody against epidermal growth factor receptors for the treatment of metastatic colorectal cancer.
PMID 18343240·Clin Ther·2008
6-review
Admissions to a medical intensive care unit related to adverse drug reactions.
PMID 17724366·Am J Health Syst Pharm·2007
8-other
Thrombotic thrombocytopenic purpura induced by metronidazole vaginal gel.
PMID 17594212·Pharmacotherapy·2007
5-case
Entecavir: a new nucleoside analogue for the treatment of chronic hepatitis B.
PMID 17460784·Drugs Today (Barc)·2007
6-review
Lubiprostone: chloride channel activator for chronic constipation.
PMID 17296458·Clin Ther·2006
6-review
Hepatocellular enzyme elevations in a patient receiving ceftriaxone.
PMID 16174837·Am J Health Syst Pharm·2005
5-case
The role of Fas-mediated apoptosis in otitis media: observations in the lpr/lpr mouse.
PMID 15978756·Hear Res·2005
7-preclinical
A review of entecavir in the treatment of chronic hepatitis B infection.
PMID 16307706·Curr Med Res Opin·2005
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- IHA RECOVERY MEDICINE, 5333 MCAULEY DRIVE, SUITE 5011
YPSILANTI, MI 48197 - Phone
- (734) 712-8700
Quick Facts
- NPI
- 1629561063
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 8
- Publications
- 20
Are you this provider?
Claim Your Profile